Search Results for: stem cells for MS

Stem cell therapy cost: if you got a treatment, how much did you pay?

stem-money

Stem cell therapy cost is a moving target. A lot depends on the circumstances. Did you get the therapy at a university or major medical center or like most people these days at a stem cell clinic? Did insurance pay any of the cost and if so, how much? If not, how did you get […]

Stem cell therapy cost: if you got a treatment, how much did you pay? Read More »

Will Right-To-Try Morph into Right-To-Profit for Stem Cell Clinics?

FDA-RMAT

On one level a reasonable argument can be made for letting terminally ill patients have a right to try experimental as yet unproven therapies, but in the real world Right-To-Try laws have many downsides. On the whole, they are likely to be negative for patients as a group.  Raising the stakes is a push for

Will Right-To-Try Morph into Right-To-Profit for Stem Cell Clinics? Read More »

Six questions as FDA takes new shot at stem cell clinics

FDA

The FDA issued a historic statement today promising to more clearly define its regulatory policies on stem cell therapies and to take strong action on some stem cell clinics that it views as “bad actors”. I’ve never the FDA use such clear-cut language before. I give big kudos to new FDA Commissioner Scott Gottlieb. It already

Six questions as FDA takes new shot at stem cell clinics Read More »

Stem cell therapy review of good news: UC Davis, Asterias, Cynata, Mesoblast, ViaCyte

VC-01-post-implant-final1-e1503703572933, viacyte

It’s a difficult, but very important road to conclusively prove that an investigational stem cell therapy is both safe and effective in order to get final approval FDA or equivalents in other countries. For this reason, it is beneficial to highlight even small, but positive steps forward including encouraging pre-clinical data. Today I’m doing a

Stem cell therapy review of good news: UC Davis, Asterias, Cynata, Mesoblast, ViaCyte Read More »

Stem cell transplants: hIPSC and hESC behave similarly in brain & often fuse with host cells

Martinez-Cerdeno-Figure-6

What happens following pluripotent stem cell transplants into the brain? Are human IPS and ES cells going to function similarly in this context? We recently published a new translational paper on the behavior of human pluripotent stem cells when transplanted into the adult mouse brain in collaboration with my great UC Davis colleague, Dr. Veronica Martinez-Cerdeno.

Stem cell transplants: hIPSC and hESC behave similarly in brain & often fuse with host cells Read More »

Lawsuit against stem cell clinic StemGenex expands to 5 patients

Stemgenex

The stem cell clinic StemGenex was sued almost a year ago related to allegations about their marketing claims. This proposed class action suit, Moorer v. StemGenex, now includes five named patients involved as one can see from the new fourth amended complaint court document. The five total named patients involved in the suit include four new

Lawsuit against stem cell clinic StemGenex expands to 5 patients Read More »

Review of Nature paper: stem cell exosomes on the brain and aging

mouse-hypothalamus-brain-and-aging

Is there a stem cell connection between the brain and aging? Could a type of brain stem cell or the exosomes it secretes control whole body aging? A recent big Nature article from the lab of Dongcheng Cai argues an emphatic “Yes” to these questions, at least in mice. In the Zhang, et al paper, entitled

Review of Nature paper: stem cell exosomes on the brain and aging Read More »

Hallelujah it’s raining money? Stem cell job ad is window into clinics & their finances

stem-cell-raining-money

“Are you a motivational speaker?” is how a recent stem cell job ad for a sales position related to stem cell clinics begins. This ad that popped up on Monster earlier this summer is a revealing window on stem cell clinic practices. What’s inside, in my opinion, is cause for concern. Lately we’ve seen more and more ads for stem

Hallelujah it’s raining money? Stem cell job ad is window into clinics & their finances Read More »

Stem cell clinic-related biz threatens researcher with lawsuit, wants retraction

turner-leigh

University of Minnesota bioethicist Leigh Turner has been threatened with a lawsuit by a stem cell clinic-related business. Lawsuit threats in this arena come up every so often and as much as they are unpleasant realities, they can also reveal some important aspects of the stem cell arena. Ars Technica reported yesterday that Leigh’s recent paper

Stem cell clinic-related biz threatens researcher with lawsuit, wants retraction Read More »